As an advocate for the genomics age, Integrated DNA Technologies (IDT), will showcase its renowned CRISPR expertise at a series of European-focused events. The genomics solution provider is well-known across the United States for its innovative nucleic acid-based products including oligonucleotides and PCR solutions, genes and gene fragments, NGS, functional genomics and CRISPR genome editing. […]Continue Reading ...
As genome editing technologies quickly advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. They are also bringing to light a number of challenges that need to be addressed before potential treatments can be widely used in patients. To tackle these challenges and fuel efforts across the country, […]Continue Reading ...
Researchers from the Cancer Science Institute of Singapore have discovered a bidirectional regulator of adenosine-to-inosine (A-to-I) RNA editing that could serve as a new cancer drug target. Image Credit: Nikolay Chaban / Shutterstock The study, which was recently published in the journal Nucleic Acids Research, found that a protein called DHX9 serves as a bidirectional […]Continue Reading ...
July 31, 2018 Despite high hopes and high investment in CRISPR-Cas9 gene editing, scientists still have a lot to learn about how it works in humans. In the latest example, University of California, Berkeley, scientists found that people’s assumptions about how cells repair the genome after the Cas9 enzyme snips DNA are wrong. The discovery […]Continue Reading ...
July 16, 2018 Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells. Reported today (16 July […]Continue Reading ...
July 10, 2018 Using genome editing to inactivate a protein called PCSK9 effectively reduces cholesterol levels in rhesus macaques, a species of monkey, according to researchers from the Perelman School of Medicine at the University of Pennsylvania. This is the first demonstration of a clinically relevant reduction of gene expression in a large animal model […]Continue Reading ...
May 14, 2018 Harvard University has granted a worldwide license to Beam Therapeutics, Inc., to develop and commercialize a suite of revolutionary DNA base editing technologies for the treatment of human disease. The versatile platform of base editing technologies was invented by David R. Liu, PhD, Professor of Chemistry and Chemical Biology, and visionary postdoctoral […]Continue Reading ...
April 27, 2018 If there is one thing all cancers have in common, it is they have nothing in common. A multi-center study led by The University of Texas MD Anderson Cancer Center has shed light on why proteins, the seedlings that serve as the incubator for many cancers, can vary from cancer to cancer […]Continue Reading ...
Credit: CC0 Public Domain New research led by the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide has uncovered a significant hurdle for realising the potential benefits of gene editing in embryos. The team, led by Professor Paul Thomas, investigated North American research published last year that seemed to demonstrate […]Continue Reading ...
August 17, 2018 An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore found that a protein, known as DHX9, acts as a bidirectional regulator of the molecular process which is linked to various types of cancer […]Continue Reading ...
By Dr Ananya Mandal, MDJuly 26, 2018 A new survey from Pew Research Center has found that nearly half of the surveyed Americans believe that in the coming 50 years, nearly all genetic birth defects could be eliminated due to advances in gene editing. CRISPR-Cas9. Image Credit: Meletios Verras Most of the participants in the […]Continue Reading ...
By Sally Robertson, BScJuly 11, 2018 A study conducted at the University of Illinois, Chicago has explained for the first time why the CRISPR gene editing tool sometimes fails to work. The study authors also suggest steps that can be taken to stop the tool from failing, which happens approximately 15% of the time. Image […]Continue Reading ...
Bernhard Schmierer, research team leader at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet. Credit: Ulf Sirborn Therapeutic use of gene editing with the CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study from Karolinska Institutet, Sweden, and the University of Helsinki, Finland, published in Nature Medicine. Researchers say […]Continue Reading ...
April 28, 2018 The Biotechnology Innovation Organization (BIO) today announced programming information for gene editing and synthetic biology at the 2018 World Congress on Industrial Biotechnology. Programming around these topics will kick off on Tuesday, July 17, with a plenary panel of experts to discuss how gene editing tools like CRISPR are revolutionizing the production […]Continue Reading ...
April 20, 2018 Delaware’s Gene Editing Institute Discovery Could Rapidly Advance Personalized Cancer Care Scientists at Christiana Care Health System’s Gene Editing Institute have developed a potentially breakthrough CRISPR gene-editing tool. It could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer […]Continue Reading ...
- Person’s sex hormones may play key role in trauma survival, finds study
- PTEN Genetic Test: MedlinePlus Lab Test Information
- Toxic metal pollution linked with development of autism spectrum disorder
- Calcified nodules in the retina increase risk for progression to late stages of AMD
- ZEISS teams up with arivis AG to offer complete 3D imaging solutions
- Georgia State professor receives $1.2 million grant to study how the brain controls eating behavior
- Specific bacterial toxins reduce number of cells suppressing immune response
- Review by ID physician improves outcomes for outpatient parenteral antimicrobial therapy
- Conditions that produce signs similar to arthritis
- AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
- Surgery remains best treatment for appendicitis, Stanford study finds
- Researchers find no link between ‘allergy friendly’ dogs and lower risk of asthma
- Researchers elucidate new rules of connectivity of neurons in the neocortex
- Treating children with ‘bubble baby disease’
- Nexus announces availability of Arsenic Trioxide Injection in the US
- Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis
- AHA: PTSD Common Among Those Who Suffer Tear in the Aorta’s Wall
- Many RA patients’ pain related to central nervous system
- Changes in Himalayan gut microbiomes linked to diet
- Inhibition of prostaglandin E2 enhances ability to combat infectious colitis